Home › Hidradenitis Suppurativa › California
Pag-aaral pangklinika para sa Hidradenitis Suppurativa sa California
12 pag-aaral para sa Hidradenitis Suppurativa ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Ctr for Dermatology Clinical Res, Fremont
- USC Keck School of Medicine, Los Angeles
- Olive View UCLA Medical Center, Sylmar
- at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Fountain Valley
- Oruka Therapeutics Investigative Site, Los Angeles
Nagre-recruitPhase 2
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07783542A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 105, Santa Monica
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Set 18, 2026 · NCT06888193Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Amicis Research Center Valencia, Northridge
- Children'S Hospital of Orange County, Orange
- Clinical Trials Research Institute, Thousand Oaks
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07049575Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US076, Fountain Valley
- Investigative Site US077, Fremont
- Investigative Site US071, Huntington Beach
- at 10 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06855498Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Northridge Clinical Trials - Northridge- Site Number : 8400005, Northridge
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07170917Clinical and Biological Characteristics of Hidradenitis Suppurativa
- University of California, San Francisco, San Francisco
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 13 pataas · Lahat ng kasarian · Na-update May 4, 2026 · NCT03967600Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
- University of California San Francisco, San Francisco
Nagre-recruitObservasyonal na pag-aaral
Edad 10 pataas · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT04115566A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- UCSF Medical Center, San Francisco
- Stanford Medical Center, Stanford
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- First OC Dermatology Research, Fountain Valley
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT072442631726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
- Wynn Medical Center Rheumatology/Dermatology, Rosemead
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 17, 2025 · NCT07155239A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Physioseq, LLC /ID# 267266, Sacramento
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ene 24, 2025 · NCT06524635Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.